You just read:

MabVax Therapeutics Phase I Trial Results of Antibody Therapy MVT-5873 for the Treatment of Advanced Pancreatic Cancer Presented at the 2017 ASCO Annual Meeting

News provided by

MabVax Therapeutics Holdings, Inc.

Jun 05, 2017, 07:00 ET